Greene Barry E
Insider CIK 1291963 · ACOR Director · ALNY President and COO · KPTI Director · RGLS Director, 10% owner · SAGE President and CEO, Director · DYN Director · CTY Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CTY CITY THERAPEUTICS, INC. | A Award deriv | 2026-10-15 | 2026-10-19 | 22,649 | — | $0 | 22,649 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2026-06-22 | 2026-06-23 | 57,463 | — | $0 | 57,463 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2026-05-21 | 2026-05-26 | 15,508 | — | $0 | 16,415 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | D To issuer deriv | 2025-07-31 | 2025-07-31 | 174,000 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | D To issuer | 2025-07-31 | 2025-07-31 | 53,229 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | U Tender | 2025-07-31 | 2025-07-31 | 46,940 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2025-05-28 | 2025-05-29 | 4,600 | — | $0 | 4,600 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2025-04-10 | 2025-04-11 | 19,964 | — | $0 | 105,031 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2025-04-10 | 2025-04-11 | 4,862 | $6.91 | $33.6K | 100,169 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2025-01-16 | 2025-01-21 | 174,000 | — | $0 | 174,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2024-08-05 | 2024-08-07 | 50,400 | — | $0 | 97,340 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2024-08-05 | 2024-08-07 | 12,273 | $8.96 | $110.0K | 85,067 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2024-05-29 | 2024-05-30 | 69,000 | — | $0 | 69,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 168,000 | — | $0 | 168,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2023-08-04 | 2023-08-08 | 195,000 | — | $0 | 195,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2023-05-24 | 2023-05-25 | 34,000 | — | $0 | 34,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2023-02-13 | 2023-02-15 | 66,500 | — | $0 | 66,500 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | P Buy | 2022-11-10 | 2022-11-15 | 14,500 | $34.48 | $500.0K | 46,940 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2022-08-11 | 2022-08-15 | 7,576 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2022-08-11 | 2022-08-15 | 7,576 | $1.49 | $11.3K | 13,606 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2022-05-19 | 2022-05-20 | 23,900 | — | $0 | 23,900 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2022-02-11 | 2022-02-15 | 69,920 | — | $0 | 69,920 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | P Buy | 2021-08-05 | 2021-08-09 | 23,640 | $43.15 | $1.02M | 32,440 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | P Buy | 2021-06-16 | 2021-06-17 | 8,800 | $56.32 | $495.6K | 8,800 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2021-06-02 | 2021-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2021-05-21 | 2021-05-21 | 23,900 | — | $0 | 23,900 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 390,000 | — | $0 | 390,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2020-10-01 | 2020-10-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-09-09 | 2020-09-11 | 44,530 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-09-09 | 2020-09-11 | 3,346 | $124.38 | $416.2K | 70,343 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-09-09 | 2020-09-11 | 27,109 | $123.39 | $3.34M | 73,689 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-09-09 | 2020-09-11 | 14,075 | $122.66 | $1.73M | 100,798 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-09-09 | 2020-09-11 | 44,530 | $9.14 | $407.0K | 114,873 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-08-10 | 2020-08-11 | 1,184 | — | $0 | 23,816 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-08-10 | 2020-08-11 | 1,587 | — | $0 | 88,413 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-08-10 | 2020-08-11 | 1,036 | — | $0 | 46,589 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-08-10 | 2020-08-11 | 1,124 | — | $0 | 38,876 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-08-10 | 2020-08-11 | 1,184 | $42.22 | $50.0K | 67,167 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-08-10 | 2020-08-11 | 1,587 | $63.00 | $100.0K | 63,823 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-08-10 | 2020-08-11 | 1,036 | $96.45 | $99.9K | 64,859 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-08-10 | 2020-08-11 | 1,124 | $88.95 | $100.0K | 65,983 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | G Gift | 2020-07-16 | 2020-09-11 | 155 | — | $0 | 3,176 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | G Gift | 2020-07-16 | 2020-09-11 | 155 | — | $0 | 3,331 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | G Gift | 2020-07-16 | 2020-09-11 | 3,176 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | G Gift | 2020-07-16 | 2020-09-11 | 155 | — | $0 | 155 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | G Gift | 2020-07-16 | 2020-09-11 | 3,176 | — | $0 | 65,412 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-07-07 | 2020-07-09 | 22,265 | — | $0 | 44,530 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-07-07 | 2020-07-09 | 22,265 | $9.14 | $203.5K | 84,501 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-07-07 | 2020-07-09 | 22,265 | $159.99 | $3.56M | 62,236 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2020-06-15 | 2020-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2020-05-21 | 2020-05-26 | 16,400 | — | $0 | 16,400 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-05-06 | 2020-05-07 | 22,265 | — | $0 | 66,795 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-05-06 | 2020-05-07 | 22,265 | $149.99 | $3.34M | 62,236 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-05-06 | 2020-05-07 | 22,265 | $9.14 | $203.5K | 84,501 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2020-04-07 | 2020-04-09 | 1,599 | $104.75 | $167.5K | 62,300 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2020-04-07 | 2020-04-09 | 5,417 | — | $0 | 63,899 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2020-04-07 | 2020-04-09 | 64 | $106.65 | $6.8K | 62,236 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-03-13 | 2020-03-17 | 3,030 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-03-13 | 2020-03-17 | 3,030 | $0.03 | $91 | 6,030 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2020-02-26 | 2020-02-28 | 29,925 | — | $0 | 29,925 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-12-23 | 2019-12-26 | 9,999 | — | $0 | 19,998 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-11-22 | 2019-11-26 | 9,999 | — | $0 | 9,999 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2019-10-23 | 2019-10-24 | 5,544 | — | $0 | 58,482 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2019-10-23 | 2019-10-24 | 5,544 | — | $0 | 3,486 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2019-10-22 | 2019-10-24 | 58,913 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2019-10-22 | 2019-10-24 | 58,913 | $16.43 | $967.9K | 111,851 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2019-10-22 | 2019-10-24 | 58,913 | $89.99 | $5.30M | 52,938 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-08-06 | 2019-08-07 | 10,000 | $88.95 | $889.5K | 40,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-08-06 | 2019-08-07 | 6,250 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2019-07-11 | 2019-08-07 | 46 | — | $0 | 3,003 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2019-06-19 | 2019-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2019-06-06 | 2019-06-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-06-05 | 2019-06-07 | 6,250 | — | $0 | 18,750 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2019-04-09 | 2019-06-07 | 52 | — | $0 | 2,957 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-02-28 | 2019-03-01 | 32,500 | — | $0 | 32,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2018-10-18 | 2019-06-07 | 21 | — | $0 | 2,905 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-09-27 | 2018-09-28 | 6,250 | — | $0 | 12,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-09-27 | 2018-09-28 | 10,000 | — | $0 | 30,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-08-21 | 2018-08-23 | 10,000 | — | $0 | 20,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-08-10 | 2018-08-14 | 15,875 | — | $0 | 47,625 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-08-10 | 2018-08-14 | 15,000 | — | $0 | 45,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | G Gift | 2018-07-31 | 2018-08-14 | 9,030 | — | $0 | 9,030 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | G Gift | 2018-07-31 | 2018-08-14 | 9,030 | — | $0 | 52,938 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2018-07-10 | 2018-08-14 | 29 | — | $0 | 2,884 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2018-06-27 | 2018-06-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2018-06-19 | 2018-06-20 | 17,000 | — | $0 | 17,000 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise deriv | 2018-05-21 | 2018-05-23 | 10,000 | — | $0 | 0 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | F Tax w/h | 2018-05-21 | 2018-05-23 | 8,727 | $23.10 | $201.6K | 1,273 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise | 2018-05-21 | 2018-05-23 | 10,000 | $20.16 | $201.6K | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2018-04-16 | 2018-08-14 | 28 | — | $0 | 2,855 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-14 | 2018-03-16 | 1,300 | $145.41 | $189.0K | 61,968 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-14 | 2018-03-16 | 9,165 | $144.67 | $1.33M | 63,268 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-14 | 2018-03-16 | 8,644 | $143.58 | $1.24M | 72,433 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-14 | 2018-03-16 | 9,217 | $142.68 | $1.32M | 81,077 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-14 | 2018-03-16 | 7,250 | $141.74 | $1.03M | 90,294 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-14 | 2018-03-16 | 2,884 | $140.43 | $405.0K | 97,544 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-03-01 | 2018-03-05 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2018-01-17 | 2018-08-14 | 17 | — | $0 | 2,827 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-12-20 | 2017-12-21 | 6,250 | — | $0 | 6,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-11-06 | 2017-11-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-10-02 | 2017-10-04 | 85,316 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-10-02 | 2017-10-04 | 85,316 | $21.35 | $1.82M | 185,744 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-10-02 | 2017-10-04 | 85,316 | $125.00 | $10.66M | 100,428 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-09-21 | 2017-09-22 | 5,359 | — | $0 | 94,641 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-09-21 | 2017-09-22 | 6,485 | — | $0 | 85,915 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-09-21 | 2017-09-22 | 5,359 | $18.66 | $100.0K | 100,428 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-09-21 | 2017-09-22 | 6,485 | $7.10 | $46.0K | 95,069 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-09-20 | 2017-09-22 | 76,815 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-09-20 | 2017-09-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-09-20 | 2017-09-22 | 76,815 | $100.00 | $7.68M | 88,584 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-09-20 | 2017-09-22 | 76,815 | $31.39 | $2.41M | 165,399 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise deriv | 2017-08-01 | 2017-08-03 | 10,000 | — | $0 | 0 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | S Sale | 2017-08-01 | 2017-08-03 | 10,000 | $21.57 | $215.7K | 0 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise | 2017-08-01 | 2017-08-03 | 10,000 | $18.21 | $182.1K | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-07-07 | 2017-07-11 | 15,875 | — | $0 | 31,750 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2017-06-15 | 2017-06-16 | 17,000 | — | $0 | 17,000 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2017-05-31 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise deriv | 2017-02-09 | 2017-02-13 | 723 | — | $0 | 0 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise | 2017-02-09 | 2017-02-13 | 723 | $22.13 | $16.0K | 723 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | S Sale | 2017-02-09 | 2017-02-13 | 723 | $22.65 | $16.4K | 0 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise deriv | 2017-01-03 | 2017-01-05 | 3,017 | — | $0 | 0 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | M Exercise | 2017-01-03 | 2017-01-05 | 3,017 | $15.91 | $48.0K | 3,017 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | S Sale | 2017-01-03 | 2017-01-05 | 3,017 | $19.26 | $58.1K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-12-20 | 2016-12-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2016-12-01 | 2016-12-05 | 55,605 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-12-01 | 2016-12-05 | 16,976 | $43.28 | $734.7K | 89,084 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-12-01 | 2016-12-05 | 500 | $44.07 | $22.0K | 88,584 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2016-12-01 | 2016-12-05 | 55,605 | $22.75 | $1.27M | 120,409 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-12-01 | 2016-12-05 | 14,349 | $42.61 | $611.4K | 106,060 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2016-06-16 | 2016-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2016-06-08 | 2016-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2016-03-24 | 2016-03-28 | 8,940 | — | $0 | 89,060 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2016-03-24 | 2016-03-28 | 7,600 | — | $0 | 92,400 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2016-03-24 | 2016-03-28 | 8,940 | $9.14 | $81.7K | 57,204 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2016-03-24 | 2016-03-28 | 7,600 | $7.10 | $54.0K | 64,804 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-02-01 | 2016-02-03 | 15,875 | — | $0 | 15,875 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-12-18 | 2015-12-22 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | G Gift | 2015-11-18 | 2015-12-22 | 2,100 | — | $0 | 48,264 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-08-04 | 2015-08-06 | 4,395 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-08-04 | 2015-08-06 | 3,185 | — | $0 | 76,815 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-08-04 | 2015-08-06 | 4,684 | — | $0 | 85,316 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-08-04 | 2015-08-06 | 6,087 | — | $0 | 58,913 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-08-04 | 2015-08-06 | 6,621 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-08-04 | 2015-08-06 | 2,000 | — | $0 | 98,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-08-04 | 2015-08-06 | 2,000 | $9.14 | $18.3K | 50,364 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-08-04 | 2015-08-06 | 6,087 | $16.43 | $100.0K | 48,364 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-08-04 | 2015-08-06 | 4,684 | $21.35 | $100.0K | 42,277 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-08-04 | 2015-08-06 | 3,185 | $31.39 | $100.0K | 37,593 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-08-04 | 2015-08-06 | 4,395 | $22.75 | $100.0K | 34,408 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-08-04 | 2015-08-06 | 6,621 | $13.12 | $86.9K | 30,013 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2015-06-09 | 2015-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-05-26 | 2015-05-28 | 67,379 | — | $0 | 6,621 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-05-26 | 2015-05-28 | 67,379 | $13.12 | $884.0K | 90,771 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-05-26 | 2015-05-28 | 67,379 | $125.00 | $8.42M | 23,392 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2015-05-22 | 2015-05-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-05-01 | 2015-05-05 | 47,625 | — | $0 | 47,625 | SEC↗ |
| KPTI Karyopharm Therapeutics In | P Buy | 2015-04-02 | 2015-04-06 | 3,000 | $29.31 | $87.9K | 3,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-12-22 | 2014-12-22 | 1,000 | — | $0 | 74,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-12-22 | 2014-12-22 | 1,000 | $13.12 | $13.1K | 23,392 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-12-19 | 2014-12-22 | 11,200 | $100.00 | $1.12M | 22,392 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2014-12-12 | 2014-12-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-11-17 | 2014-11-19 | 33,200 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-11-17 | 2014-11-19 | 9,579 | $89.81 | $860.3K | 39,154 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-11-17 | 2014-11-19 | 5,462 | $90.96 | $496.8K | 33,692 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-11-17 | 2014-11-19 | 100 | $93.99 | $9.4K | 33,592 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-11-17 | 2014-11-19 | 18,059 | $89.11 | $1.61M | 48,733 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-11-17 | 2014-11-19 | 33,200 | $6.78 | $225.1K | 66,792 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-11-11 | 2014-11-13 | 11,100 | — | $0 | 33,200 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-11-11 | 2014-11-13 | 11,100 | $100.00 | $1.11M | 33,592 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-11-11 | 2014-11-13 | 11,100 | $6.78 | $75.3K | 44,692 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2014-07-08 | 2014-07-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2014-06-05 | 2014-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-02-03 | 2014-02-04 | 19,500 | — | $0 | 44,300 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-02-03 | 2014-02-04 | 19,500 | $6.78 | $132.2K | 35,272 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2014-02-03 | 2014-02-04 | 1,680 | $78.68 | $132.2K | 33,592 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2013-12-18 | 2013-12-18 | 90,000 | — | $0 | 90,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-12-17 | 2013-12-18 | 11,200 | — | $0 | 47,796 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-12-17 | 2013-12-18 | 11,200 | $6.78 | $75.9K | 15,772 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2013-10-21 | 2013-10-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2013-05-30 | 2013-06-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-05-28 | 2013-05-30 | 14,928 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-05-28 | 2013-05-30 | 7,894 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-05-28 | 2013-05-30 | 14,928 | $0.95 | $14.2K | 19,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-05-28 | 2013-05-30 | 7,894 | $0.95 | $7.5K | 12,466 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-05-28 | 2013-05-30 | 7,894 | $30.00 | $236.8K | 4,572 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-05-28 | 2013-05-30 | 14,928 | $30.00 | $447.8K | 4,572 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-03-14 | 2013-03-18 | 24,058 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-03-14 | 2013-03-18 | 24,058 | $0.95 | $22.9K | 28,630 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-03-14 | 2013-03-18 | 24,058 | $25.00 | $601.5K | 4,572 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-03-08 | 2013-03-11 | 24,000 | — | $0 | 24,058 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-03-08 | 2013-03-11 | 24,000 | $24.43 | $586.3K | 4,572 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-03-08 | 2013-03-11 | 24,000 | $0.95 | $22.8K | 28,572 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2012-12-20 | 2012-12-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2012-11-05 | 2012-11-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | C Conversion deriv | 2012-10-10 | 2012-10-11 | 6,150,500 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | C Conversion | 2012-10-10 | 2012-10-11 | 6,150,500 | — | $0 | 6,150,500 | SEC↗ |
| ACOR ACORDA THERAPEUTICS INC | A Award deriv | 2012-06-06 | 2012-06-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | P Buy | 2012-02-21 | 2012-02-23 | 1,860 | $10.75 | $20.0K | 4,572 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | P Buy | 2012-01-09 | 2012-01-11 | 567 | $8.80 | $5.0K | 2,712 | SEC↗ |